Those with kidney disease, active cancer, or thyroid concerns should discuss alternatives with their provider
In the United States, FDA guidelines indicate these medications for: Adults with a BMI of 30 or higher (obesity) Adults with a BMI of 27 or higher who also have at least one weight-related health condition, such as type 2 diabetes, high blood pressure, high cholesterol, or obstructive sleep apnea You should discuss GLP-1 medications with a physician if you have any of the following, as they may affect which medication is appropriate or require additional monitoring: Personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN2) a contraindication for all GLP-1 drugs History of pancreatitis Kidney disease or a history of gallstones Pregnancy or plans to become pregnant History of eating disorders The Critical Factor Most People Overlook: Muscle Loss Here is something that rarely appears in GLP-1 marketing: these medications can cause significant muscle loss alongside fat loss, particularly at the aggressive weight loss rates they enable
Desperate people will still flock to them in the face of chronic pain or terminal illness, encouraged by emotional testimonials, and some of them will feel an improvement
Whether its exploring new treatment methods or utilizing trusted injection therapies, RXIV Infusions is committed to helping clients find solutions that fit their lifestyle and health goals
Peroxidation of specific membrane lipids is the ultimate driver of ferroptosis (Stockwell, 2022)
That year, an estimated 8.2 million prescriptions for it were written in the U.S., more than quadruple the number just two years earlier
